These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20860534)

  • 1. HIV-1 drug resistance transmission networks in southwest Switzerland.
    Castro E; Khonkarly M; Ciuffreda D; Bürgisser P; Cavassini M; Yerly S; Pantaleo G; Bart PA
    AIDS Res Hum Retroviruses; 2010 Nov; 26(11):1233-8. PubMed ID: 20860534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance.
    Kousiappa I; van de Vijver DA; Demetriades I; Kostrikis LG
    AIDS Res Hum Retroviruses; 2009 Jan; 25(1):23-35. PubMed ID: 19182918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study.
    Drescher SM; von Wyl V; Yang WL; Böni J; Yerly S; Shah C; Aubert V; Klimkait T; Taffé P; Furrer H; Battegay M; Ambrosioni J; Cavassini M; Bernasconi E; Vernazza PL; Ledergerber B; Günthard HF; Kouyos RD;
    Clin Infect Dis; 2014 Jan; 58(2):285-94. PubMed ID: 24145874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular diversity and polymerase gene genotypes of HIV-1 among treatment-naïve Cameroonian subjects with advanced disease.
    Soares EA; Makamche MF; Siqueira JD; Lumngwena E; Mbuagbaw J; Kaptue L; Asonganyi T; Seuánez HN; Soares MA; Alemnji G
    J Clin Virol; 2010 Jul; 48(3):173-9. PubMed ID: 20483657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the diversity of the HIV-1 pol gene and drug resistance associated changes among drug-naïve patients in Burkina Faso.
    Tebit DM; Sangaré L; Tiba F; Saydou Y; Makamtse A; Somlare H; Bado G; Kouldiaty BG; Zabsonre I; Yameogo SL; Sathiandee K; Drabo JY; Kräusslich HG
    J Med Virol; 2009 Oct; 81(10):1691-701. PubMed ID: 19697403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of distinct human immunodeficiency virus type 1 circulating recombinant forms in northeast Brazil.
    Santos LA; Monteiro-Cunha JP; Araujo AF; Brites C; Galvao-Castro B; Alcantara LC
    J Med Virol; 2011 Dec; 83(12):2066-72. PubMed ID: 22012712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High level of multidrug resistance mutations in HIV type 1 pol gene and resistance-associated mutations to enfuvirtide (T-20) among antiretroviral-experienced patients from central Brazil.
    Cardoso LP; Stefani MM
    AIDS Res Hum Retroviruses; 2009 Oct; 25(10):943-50. PubMed ID: 19792869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.
    de Mulder M; Yebra G; Martín L; Prieto L; Mellado MJ; Rojo P; Muñoz-Fernández MÁ; Jiménez de Ory S; Ramos JT; Holguín A;
    J Antimicrob Chemother; 2011 Oct; 66(10):2362-71. PubMed ID: 21810838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
    Cardoso LP; Queiroz BB; Stefani MM
    J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.
    Ceccarelli L; Salpini R; Moudourou S; Cento V; Santoro MM; Fokam J; Takou D; Nanfack A; Dori L; Torimiro J; Sarmati L; Andreoni M; Perno CF; Colizzi V; Cappelli G
    J Med Virol; 2012 May; 84(5):721-7. PubMed ID: 22431019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High burden of transmitted HIV-1 drug resistance in Italian patients carrying F1 subtype.
    Franzetti M; Lai A; Simonetti FR; Bozzi G; De Luca A; Micheli V; Meraviglia P; Corsi P; Bagnarelli P; Almi P; Zoncada A; Balotta C
    J Antimicrob Chemother; 2012 May; 67(5):1250-3. PubMed ID: 22302564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in drug resistance patterns following the introduction of HIV type 1 non-B subtypes in Spain.
    De Mendoza C; Garrido C; Poveda E; Corral A; Zahonero N; Treviño A; Anta L; Soriano V
    AIDS Res Hum Retroviruses; 2009 Oct; 25(10):967-72. PubMed ID: 19842792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New trends of primary drug resistance among HIV type 1-infected men who have sex with men in Liaoning Province, China.
    Zhao B; Han X; Dai D; Liu J; Ding H; Xu J; Chu Z; Bice T; Diao Y; Shang H
    AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1047-53. PubMed ID: 21417755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Genetics and the Incidence of Transmitted Drug Resistance Among Pre-Treatment HIV-1 Infected Patients in the Eastern Cape, South Africa.
    Digban TO; Iweriebor BC; Obi LC; Nwodo U; Okoh AI
    Curr HIV Res; 2019; 17(5):335-342. PubMed ID: 31584370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of drug resistance in therapy-naïve HIV infected patients and detection of African HIV subtypes in Hungary.
    Kanizsai S; Ghidán A; Ujhelyi E; Bánhegyi D; Nagy K
    Acta Microbiol Immunol Hung; 2010 Mar; 57(1):55-68. PubMed ID: 20350879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular diversity of HIV-1 and surveillance of transmitted drug resistance variants among treatment Naïve patients, 5 years after active introduction of HAART in Kuala Lumpur, Malaysia.
    Ong LY; Razak SN; Lee YM; Sri La Sri Ponnampalavanar S; Syed Omar SF; Azwa RI; Tee KK; Kamarulzaman A
    J Med Virol; 2014 Jan; 86(1):38-44. PubMed ID: 24127302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in the HIV-1 gp41 env gene, natural resistance to enfuvirtide (T-20) and pol resistance among pregnant Brazilian women.
    Reis MN; de Alcântara KC; Cardoso LP; Stefani MM
    J Med Virol; 2014 Jan; 86(1):8-17. PubMed ID: 24037943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-circulation HIV-1 subtypes B, C, and CRF31_BC in a drug-naïve population from Southernmost Brazil: analysis of primary resistance mutations.
    de Medeiros RM; Junqueira DM; Matte MC; Barcellos NT; Chies JA; Matos Almeida SE
    J Med Virol; 2011 Oct; 83(10):1682-8. PubMed ID: 21837783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in Santos, Brazil.
    de Sa-Filho DJ; Soares Mda S; Candido V; Gagliani LH; Cavaliere E; Diaz RS; Caseiro MM
    AIDS Res Hum Retroviruses; 2008 Mar; 24(3):347-53. PubMed ID: 18327988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary antiretroviral drug resistance among HIV type 1-infected individuals in Brazil.
    Sprinz E; Netto EM; Patelli M; Lima JS; Furtado JJ; da Eira M; Zajdenverg R; Madruga JV; Lewi DS; Machado AA; Pedro RJ; Soares MA
    AIDS Res Hum Retroviruses; 2009 Sep; 25(9):861-7. PubMed ID: 19689190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.